Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05889468 · ClinicalTrials.gov registry record · Phase 4
Postpartum ASA and NT-proBNP
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 114
- Enrollment target
NCT05889468 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 114 participants.
The verdict
NCT05889468, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 114 participants
- Enrollment target
Study Summary
This study is a double-blinded randomized-controlled trial in which patients will be randomized to 81 mg of aspirin or placebo to be continued for 6 weeks' postpartum. The purpose of this study is to compare NT-proBNP levels at the 4-6 week postpartum visit between groups. There is currently no data on the maternal health effects associated with continuation of low-dose aspirin in the postpartum period. This study aims to fill a gap in the knowledge regarding the utility of low-dose aspirin following delivery.
Interventions
- DRUG Placebo
- DRUG Aspirin 81Mg Ec Tab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2024-05-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05889468
The ClinicalTrials.gov registry entry for NCT05889468 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05889468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05889468 about?
NCT05889468 is a clinical study titled "Postpartum ASA and NT-proBNP". This study is a double-blinded randomized-controlled trial in which patients will be randomized to 81 mg of aspirin or placebo to be continued for 6 weeks' postpartum. The purpose of this study is to compare NT-proBNP levels at the 4-6 week postpartum visit between groups. There is currently no data...
What is the current status of trial NCT05889468?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 114 participants. The study started on 2023-07-01. Estimated completion is 2024-05-21.
What interventions are being tested in trial NCT05889468?
The interventions under investigation include: Placebo (DRUG), Aspirin 81Mg Ec Tab (DRUG).
Who is sponsoring clinical trial NCT05889468?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.